Jingyi D. Zhou
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Development of potent and selective ENPP1 inhibitors based on imidazo[1,2-a]pyrazine and pyrazine scaffolds for cancer immunotherapy.
Journal: European journal of medicinal chemistry
Published: June 29, 2026
Discovery, biological evaluation, and molecular modeling of novel alkylamine-based Cbl-b inhibitors.
Discovery, biological evaluation, and molecular modeling of novel alkylamine-based Cbl-b inhibitors.
Journal: Bioorganic chemistry
Published: March 02, 2026
Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulation in pancreatic cancer.
Journal: Biomaterials
Published: February 03, 2026
Correction: Protective role of circrna CCND1 in ulcerative colitis via miR-142-5p/NCOA3 axis.
Journal: BMC gastroenterology
Published: December 16, 2025
A Supramolecular Nanoscavengers: Based "Cargo-Exchange" Breaking Cholesterol Metabolic Dysregulation for Glioblastoma Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 05, 2025
Shutting Down the 'Language Encoder': A Pathogen-Derived Nano-Interferer Disrupt Sialylation Metabolism and Reprogram Intercellular Communication in Glioblastoma.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 26, 2025
VHH-Based CAR-T Cells Targeting DLL3 Show High Efficacy in Small Cell Lung Cancer Models.
Journal: Molecular cancer therapeutics
Published: August 14, 2025
POSTN+ CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy.
Journal: Research (Washington, D.C.)
Published: July 15, 2025
Fertility under fire: how chemotherapy harms the ovaries and the science fighting back?
Journal: Journal of ovarian research
Published: July 09, 2025
Krüppel-Like Factor 4, a Hub Gate for Cell Crosstalk in Tumor Microenvironment.
Journal: Cancer medicine
Published: July 06, 2025
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models.
Journal: The Journal of clinical investigation
Published: June 10, 2025
Gestational age-specific changes and reference intervals of coagulation parameters and early biomarkers of thrombosis in Chinese pregnant women.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: June 09, 2025
Last Updated: 09/26/2026